NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 5.41
-0.29 (-5.09%)
At close: Mar 3, 2026
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 430.9 million as of March 4, 2026. Its market cap has increased by 103.35% in one year.
Market Cap
430.90M
Enterprise Value
419.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.41
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 430.90M, an increase of 760.58%. That is a compound annual growth rate of 36.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 454.00M | -25.73% |
| Dec 31, 2025 | 611.28M | 176.89% |
| Dec 31, 2024 | 220.77M | 37.18% |
| Dec 29, 2023 | 160.94M | 71.42% |
| Dec 30, 2022 | 93.89M | -24.19% |
| Dec 31, 2021 | 123.84M | 58.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 1.09B |
| Eupraxia Pharmaceuticals | 683.63M |
| Satellos Bioscience | 368.19M |
| Helix BioPharma | 150.46M |
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 73.41M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 58.99M |